Medical Disorders
Resources
Basic InformationLookupsLatest News
Face Masks, Yes, But Don't Forget Hand-Washing TooEven With PPE, Risk of COVID-19 Still High for Frontline WorkersCoronavirus Pandemic Becoming Far More Widespread, Birx SaysGuard Against Lyme Disease This SummerKids 'Efficient' Transmitters as COVID-19 Raced Through a Georgia Summer CampCollege Students Will Need COVID Tests Every 2-3 Days for Campus Safety: StudyAHA News: Sustained High Blood Pressure May Damage Brain VesselsAnother Side Effect of COVID-19 -- Lasting Hearing Problems?Pandemic Could Complicate Hurricane SeasonStudy Reveals How Coronavirus Travels IndoorsNew Study Sheds Doubt on Notion Kids Aren't COVID-19 SpreadersAHA News: Are Virtual Doctor Visits Safe for Discharged Heart Failure Patients?Double Lung Transplants Save Lives of Sickest COVID PatientsGynecological Cancers Not a Risk for Severe COVID-19: Study11 States Could Face ICU Doc Shortages as Coronavirus Cases SurgeWildfire Pollution Puts Kidney Patients at RiskAmerica's Progress Against Early Cardiovascular Death Is SlowingAHA News: 5 Easy Ways to Keep Tabs on Heart HealthGene Study Shows How Coronavirus Swept Through the Diamond PrincessOne Disease Mosquitoes Don't Spread: CoronavirusU.S. Coronavirus Death Toll Surges Past 150,000Do Bedbugs Dirty the Air Inside Your Home?AHA News: New Test May Predict Who Develops Certain Type of Heart FailureLess Smoking, Drinking Means Fewer Hip Fractures for AmericansYet Another Study Finds Vaccines Are SafeCommon Diabetes Meds Linked to Higher Odds for a Serious ComplicationSurvivors' COVID Antibodies May Provide a Powerful GiftConcussion Ups Odds for Many Brain ConditionsFinal Coronavirus Vaccine Trials Get UnderwayAHA News: Flu Shot May Help Protect Vulnerable Hospital Patients From Heart Attack, Mini-StrokeIn Rush to Publish, Most COVID-19 Research Isn't Reliable, Experts SayGlaucoma Checkups Fall by the Wayside During PandemicLab-Created Virus Can Help COVID-19 Research, Developers SayHow to Counter the Anti-Mask Backlash? Empathy.States With Soaring COVID Cases Must Take Action, U.S. Health Officials SayWhat Puts You at High Risk of Midlife Mental Decline?AHA News: Controlling Diabetes Takes on Greater Urgency During COVID-19 PandemicMany U.S. Homes Too Cramped to Stop COVID-19's SpreadCDC Issues Call to Reopen America's Schools This FallMore Layers Are Better With Homemade Face MasksWith Safety Steps, Moms Unlikely to Pass COVID-19 to Newborns: StudyU.S. Coronavirus Cases Pass 4 Million, Third Day of Over 1,000 Deaths LoggedChronic Conditions Tied to Severe COVID-19 More Common in Southeast, Rural AreasSteroids Other Than Dexamethasone May Also Help Battle COVID-19COVID-19 Jitters Shouldn't Keep You From the Emergency RoomExpert Tips to Help You Beat the HeatU.S. Coronavirus Cases Near 4 Million as Death Toll Tops 1,000 for Second DayAntibodies Fade a Few Weeks After Mild COVID-19, Study FindsEarly Dialysis Doesn't Improve Outcomes With Acute Kidney FailureFor Cancer Patients, Getting COVID-19 Raises Death Risk 16-Fold
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Thyroid Drug May Not Help After Heart Attack: Study

HealthDay News
by -- E.J. Mundell
Updated: Jul 21st 2020

new article illustration

TUESDAY, July 21, 2020 (HealthDay News) -- If a heart attack survivor also has an underactive thyroid, treating them with supplemental thyroid hormone probably won't help, new research shows.

The study found that use of the hormonal drug, called levothyroxine, didn't improve heart muscle function in heart attack patients diagnosed with "subclinical hypothyroidism" -- an underactive thyroid.

In fact, "screening for and subsequent treatment of subclinical hypothyroidism in patients who have had a heart attack to preserve or improve heart function is not justified," concluded the study's lead author, Salman Razvi. He's a consultant endocrinologist at Newcastle University and the Queen Elizabeth Hospital in Gateshead, U.K.

Mild or subclinical hypothyroidism -- which affects about 10% of adults -- means that the thyroid doesn't produce enough hormones.

Management of the condition is uneven because there's a lack of good evidence either for or against treatment, Razvi's team noted.

Dr. Satjit Bhusri is a cardiologist at Lenox Hill Hospital in New York City. He wasn't involved in the new research but said that, in the United States, guidelines for heart patients "generally do not recommend checking thyroid function unless there is an indication that's related to an arrhythmia [irregular heartbeat]."

The new British study included 46 heart attack survivors who had received levothyroxine and 49 who received a "dummy" placebo.

A year into treatment, heart function had improved in both groups, the researchers said, but there was no greater improvement in those who'd received levothyroxine.

The findings suggest that levothyroxine does not improve heart function in patients who've had a heart attack and is unlikely to be beneficial, Razvi's group said.

"The results of this trial will help clinicians reconsider offering treatment with levothyroxine to tens of thousands of patients with subclinical hypothyroidism worldwide," Razvi said in a university news release.

"To any patient who has had a heart attack and has been diagnosed with subclinical hypothyroidism, I would advise that they consult their [doctor] on whether levothyroxine is likely to be of benefit," he added. "The results of our trial suggest that all such patients should have their thyroid function rechecked after a few weeks. Treatment with levothyroxine should not be started routinely in such patients."

Dr. Benjamin Hirsh directs preventive cardiology at Northwell Health's Sandra Atlas Bass Heart Hospital in Manhasset, N.Y. Reviewing the new findings, he noted that "subclinical hypothyroidism is a milder form of hypothyroidism that's more common than true primary hypothyroidism." According to Hirsh, subclinical hypothyroidism "affects approximately 5% of the population."

Hirsh said that the study appears to recommend against the use of levothyroxine in heart attack patients with subclinical hypothyroidism. However, he also believes that the study's methodology provided only a "narrow scope" in measuring the benefit of treatment for the heart.

Also, "the sample size of the study is quite small, and it is difficult to make a strong conclusion either way given this limitation," Hirsh said.

The study was published July 21 in the Journal of the American Medical Association.

More information

The U.S. National Library of Medicine has more on hypothyroidism.




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net